← FDA Drug Approvals (Drugs@FDA)

SESQUIENT

NDA · New Drug Application · Sponsor: LUPIN · Approved 2020-11-05

Drug application

FDA Application #

NDA210864

Application type

New Drug Application

Brand name

SESQUIENT

Generic name

Fosphenytoin Sodium

Active ingredients

FOSPHENYTOIN SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

LUPIN

First approval

2020-11-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown